{"id":472,"date":"2019-01-23T09:22:47","date_gmt":"2019-01-23T08:22:47","guid":{"rendered":"https:\/\/www.comll.cat\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/"},"modified":"2019-01-23T09:22:47","modified_gmt":"2019-01-23T08:22:47","slug":"jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos","status":"publish","type":"post","link":"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/","title":{"rendered":"Jornada. C\u00e1ncer Hematol\u00f3gico: de la Investigaci\u00f3n Cl\u00ednica al Acceso de Medicamentos"},"content":{"rendered":"

Con motivo de la celebraci\u00f3n del D\u00eda Mundial contra el C\u00e1ncer, hemos querido establecer una panor\u00e1mica de la situaci\u00f3n del c\u00e1ncer hematol\u00f3gico en Espa\u00f1a, desde la investigaci\u00f3n cl\u00ednica al acceso de medicamentos, pasando por los diferentes aspectos que plantea su abordaje.<\/p>\n

La Jornada, organizada conjuntamente por la Sociedad Espa\u00f1ola de Hematolog\u00eda y Hemoterapia SEHH, y la Fundaci\u00f3n para la Investigaci\u00f3n en Salud FUINSA<\/strong>, llevar\u00e1 por t\u00edtulo \"C\u00e1ncer Hematol\u00f3gico: de la Investigaci\u00f3n Cl\u00ednica al Acceso de Medicamentos\"<\/strong>.<\/p>\n

Adjuntamos el programa de la jornada:<\/p>\n

PRESENTACI\u00d3N <\/u><\/strong><\/p>\n

Ministerio de Sanidad Consumo y Bienestar Social<\/strong>. Pendiente confirmaci\u00f3n.<\/p>\n

Alfonso Moreno<\/strong>. Presidente de la Fundaci\u00f3n para la Investigaci\u00f3n en Salud FUINSA.<\/p>\n

Jorge Sierra<\/strong>. Presidente de la Sociedad Espa\u00f1ola de Hematolog\u00eda y Hemoterapia SEHH.<\/p>\n

In\u00e9s Entrecanales<\/strong>. Vicepresidenta de la Asociaci\u00f3n Espa\u00f1ola contra el C\u00e1ncer AECC.<\/p>\n

CONFERENCIA: EL C\u00c1NCER HEMATOL\u00d3GICO EN LA ESTRATEGIA EN C\u00c1NCER DEL SNS<\/u><\/strong><\/p>\n

Josep Mar\u00eda Borr\u00e1s Andr\u00e9s<\/strong>. Coordinador Cient\u00edfico de la Estrategia contra el c\u00e1ncer del SNS. Universidad de Barcelona.<\/p>\n

MESA 1: INVESTIGACI\u00d3N<\/u><\/strong><\/p>\n

Investigaci\u00f3n espa\u00f1ola en c\u00e1ncer hematol\u00f3gico: el mieloma m\u00faltiple como modelo<\/p>\n

Juan Jos\u00e9 Lahuerta. <\/strong>Coordinador del Grupo Espa\u00f1ol de Mieloma (GEM-PETHEMA). Hospital Universitario 12 de Octubre. Madrid.<\/p>\n

Proyecto HARMONY<\/p>\n

Jes\u00fas Mar\u00eda Hern\u00e1ndez Rivas<\/strong>. Coordinador Proyecto HARMONY.\u00a0 Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca (IBSAL).<\/strong><\/p>\n

\u00bfEs necesario un CIBER en Hematolog\u00eda?<\/p>\n

Pendiente confirmaci\u00f3n.<\/em><\/p>\n

Papel de la Industria Farmac\u00e9utica<\/p>\n

Javier Urzay<\/strong>. Subdirector General de Farmaindustria.<\/p>\n

MESA 2 \u2013 ABORDAJE (DIAGN\u00d3STICO Y TRATAMIENTO)<\/u><\/strong><\/p>\n

Avances diagn\u00f3sticos<\/p>\n

Ram\u00f3n Garc\u00eda Sanz<\/strong>. Presidente Electo de la SEHH. Hospital Universitario de Salamanca.<\/p>\n

Medicina de precisi\u00f3n<\/p>\n

Jorge Sierra<\/strong>. Presidente de la SEHH.<\/p>\n

Inmunoterapia<\/p>\n

Pendiente confirmaci\u00f3n.<\/em><\/p>\n

Terapia CAR<\/p>\n

Pendiente confirmaci\u00f3n.<\/em><\/p>\n

MESA 3 \u2013 ACCESO<\/u><\/strong><\/p>\n

Pacientes<\/p>\n

Natacha Bola\u00f1os. <\/strong>Coordinadora de Lymphoma Coalition Europe.<\/p>\n

GEDEFO-SEFH<\/p>\n

Irene Mangues. <\/strong>Unitat de Farm\u00e0cia Oncohematol\u00f2gica. Hospital Universitari Arnau de Vilanova. Lleida.<\/p>\n

Terapias Avanzadas de la Comunidad de Madrid<\/p>\n

Encarnaci\u00f3n Cruz<\/strong>. Coordinadora de Terapias Avanzadas de la Comunidad de Madrid.<\/p>\n

Direcci\u00f3n General de Cartera B\u00e1sica de Servicios del Sistema Nacional de Salud y Farmacia. MSCBS.<\/p>\n

Pendiente confirmaci\u00f3n.<\/em><\/p>\n

CLAUSURA<\/strong><\/p>\n

 <\/p>\n

La INSCRIPCI\u00d3N es GRATUITA, si bien debe formalizar su solicitud. M\u00e1s informaci\u00f3n <\/strong><\/p>\n

http:\/\/www.fuinsa.org\/em-actividades\/cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

Con motivo de la celebraci\u00f3n del D\u00eda Mundial contra el C\u00e1ncer, hemos querido establecer una panor\u00e1mica de la situaci\u00f3n del...<\/p>\n","protected":false},"author":1,"featured_media":421,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[18],"tags":[],"class_list":["post-472","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"acf":[],"yoast_head":"\nJornada. C\u00e1ncer Hematol\u00f3gico: de la Investigaci\u00f3n Cl\u00ednica al Acceso de Medicamentos - Col\u00b7legi Oficial de Metges de Lleida<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jornada. C\u00e1ncer Hematol\u00f3gico: de la Investigaci\u00f3n Cl\u00ednica al Acceso de Medicamentos - Col\u00b7legi Oficial de Metges de Lleida\" \/>\n<meta property=\"og:description\" content=\"Con motivo de la celebraci\u00f3n del D\u00eda Mundial contra el C\u00e1ncer, hemos querido establecer una panor\u00e1mica de la situaci\u00f3n del...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi Oficial de Metges de Lleida\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-23T08:22:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.comll.cat\/es\/wp-content\/uploads\/sites\/3\/news-form-comll.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Albert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\\\/\"},\"author\":{\"name\":\"Albert\",\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/#\\\/schema\\\/person\\\/1c7bc4d83b35a927d680cfe0ec9120e0\"},\"headline\":\"Jornada. C\u00e1ncer Hematol\u00f3gico: de la Investigaci\u00f3n Cl\u00ednica al Acceso de Medicamentos\",\"datePublished\":\"2019-01-23T08:22:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\\\/\"},\"wordCount\":414,\"image\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/news-form-comll.jpg\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\\\/\",\"url\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\\\/\",\"name\":\"Jornada. C\u00e1ncer Hematol\u00f3gico: de la Investigaci\u00f3n Cl\u00ednica al Acceso de Medicamentos - Col\u00b7legi Oficial de Metges de Lleida\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/news-form-comll.jpg\",\"datePublished\":\"2019-01-23T08:22:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/#\\\/schema\\\/person\\\/1c7bc4d83b35a927d680cfe0ec9120e0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.comll.cat\\\/es\\\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/news-form-comll.jpg\",\"contentUrl\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/news-form-comll.jpg\",\"width\":1280,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jornada. C\u00e1ncer Hematol\u00f3gico: de la Investigaci\u00f3n Cl\u00ednica al Acceso de Medicamentos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/\",\"name\":\"Col\u00b7legi Oficial de Metges de Lleida\",\"description\":\"COMLL\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/#\\\/schema\\\/person\\\/1c7bc4d83b35a927d680cfe0ec9120e0\",\"name\":\"Albert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c1261138a5e7882394bd9001104fe7078a2d860997555a5353af4ef7bd38f6db?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c1261138a5e7882394bd9001104fe7078a2d860997555a5353af4ef7bd38f6db?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c1261138a5e7882394bd9001104fe7078a2d860997555a5353af4ef7bd38f6db?s=96&d=mm&r=g\",\"caption\":\"Albert\"},\"sameAs\":[\"https:\\\/\\\/www.comll.cat\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Jornada. C\u00e1ncer Hematol\u00f3gico: de la Investigaci\u00f3n Cl\u00ednica al Acceso de Medicamentos - Col\u00b7legi Oficial de Metges de Lleida","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/","og_locale":"es_ES","og_type":"article","og_title":"Jornada. C\u00e1ncer Hematol\u00f3gico: de la Investigaci\u00f3n Cl\u00ednica al Acceso de Medicamentos - Col\u00b7legi Oficial de Metges de Lleida","og_description":"Con motivo de la celebraci\u00f3n del D\u00eda Mundial contra el C\u00e1ncer, hemos querido establecer una panor\u00e1mica de la situaci\u00f3n del...","og_url":"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/","og_site_name":"Col\u00b7legi Oficial de Metges de Lleida","article_published_time":"2019-01-23T08:22:47+00:00","og_image":[{"width":1280,"height":900,"url":"https:\/\/www.comll.cat\/es\/wp-content\/uploads\/sites\/3\/news-form-comll.jpg","type":"image\/jpeg"}],"author":"Albert","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/#article","isPartOf":{"@id":"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/"},"author":{"name":"Albert","@id":"https:\/\/www.comll.cat\/es\/#\/schema\/person\/1c7bc4d83b35a927d680cfe0ec9120e0"},"headline":"Jornada. C\u00e1ncer Hematol\u00f3gico: de la Investigaci\u00f3n Cl\u00ednica al Acceso de Medicamentos","datePublished":"2019-01-23T08:22:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/"},"wordCount":414,"image":{"@id":"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.comll.cat\/es\/wp-content\/uploads\/sites\/3\/news-form-comll.jpg","articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/","url":"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/","name":"Jornada. C\u00e1ncer Hematol\u00f3gico: de la Investigaci\u00f3n Cl\u00ednica al Acceso de Medicamentos - Col\u00b7legi Oficial de Metges de Lleida","isPartOf":{"@id":"https:\/\/www.comll.cat\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/#primaryimage"},"image":{"@id":"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.comll.cat\/es\/wp-content\/uploads\/sites\/3\/news-form-comll.jpg","datePublished":"2019-01-23T08:22:47+00:00","author":{"@id":"https:\/\/www.comll.cat\/es\/#\/schema\/person\/1c7bc4d83b35a927d680cfe0ec9120e0"},"breadcrumb":{"@id":"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/#primaryimage","url":"https:\/\/www.comll.cat\/es\/wp-content\/uploads\/sites\/3\/news-form-comll.jpg","contentUrl":"https:\/\/www.comll.cat\/es\/wp-content\/uploads\/sites\/3\/news-form-comll.jpg","width":1280,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.comll.cat\/es\/jornada-cancer-hematologico-de-la-investigacion-clinica-al-acceso-de-medicamentos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.comll.cat\/es\/"},{"@type":"ListItem","position":2,"name":"Jornada. C\u00e1ncer Hematol\u00f3gico: de la Investigaci\u00f3n Cl\u00ednica al Acceso de Medicamentos"}]},{"@type":"WebSite","@id":"https:\/\/www.comll.cat\/es\/#website","url":"https:\/\/www.comll.cat\/es\/","name":"Col\u00b7legi Oficial de Metges de Lleida","description":"COMLL","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.comll.cat\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.comll.cat\/es\/#\/schema\/person\/1c7bc4d83b35a927d680cfe0ec9120e0","name":"Albert","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/c1261138a5e7882394bd9001104fe7078a2d860997555a5353af4ef7bd38f6db?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c1261138a5e7882394bd9001104fe7078a2d860997555a5353af4ef7bd38f6db?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c1261138a5e7882394bd9001104fe7078a2d860997555a5353af4ef7bd38f6db?s=96&d=mm&r=g","caption":"Albert"},"sameAs":["https:\/\/www.comll.cat"]}]}},"publishpress_future_action":{"enabled":false,"date":"2026-05-25 22:31:20","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/posts\/472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/comments?post=472"}],"version-history":[{"count":0,"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/posts\/472\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/media\/421"}],"wp:attachment":[{"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/media?parent=472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/categories?post=472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/tags?post=472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}